Generic Name
Empagliflozin + Linagliptin + Metformin XR
Indications
Empozin 3XR (Empagliflozin + Linagliptin + Metformin XR) is a combination medication used to treat type 2 diabetes. It works by: Empagliflozin: Increases glucose removal from the kidneys, reducing blood sugar levels. Linagliptin: Helps the body produce more insulin and reduces glucose production in the liver. Metformin: Decreases sugar production by the liver and improves the body’s sensitivity to insulin. This combination is particularly effective for individuals who require multiple approaches to manage their diabetes, especially when diet and exercise alone are insufficient.
Strength
5/2.5/1000 mg, 10/5/1000 mg, 12.5/2.5/1000 mg, 25/5/1000 mg
Pack Size
14’s
Dosage Form
Extended-Release Tablets
Categories
Pharmaceutical
Therapeutic Class
Anti-Diabetic
